CCEM(SZ:300655)2025-01-22 10:35Financial Performance Expectations - The company expects a net loss attributable to shareholders of approximately 15,000 to 22,000 thousand RMB for the fiscal year 2024, representing a decline of 1,111.95% to 1,584.20% compared to the previous year's profit of 1,482.28 thousand RMB[3]. - The net profit after deducting non-recurring gains and losses is projected to be a loss of 14,400 to 21,000 thousand RMB, a decrease of 429.22% to 580.12% from the previous year's profit of 4,373.91 thousand RMB[3]. Reasons for Expected Loss - The primary reasons for the expected loss include a decline in sales prices of key lithium battery materials and high-purity chemicals despite an increase in overall shipment volume and market share[5]. Impairment and Asset Valuation - The company plans to recognize an impairment provision of approximately 14,500 thousand RMB for goodwill and about 1,600 thousand RMB for asset impairment due to a cautious assessment of asset values[5]. Research and Development Investments - Significant increases in R&D expenditures are anticipated for 2024, particularly for high-end photoresist products such as ArF and KrF, leading to a substantial rise in overall R&D costs[5]. Production Capacity and Depreciation - The company has completed the construction of new production lines for semiconductor-grade high-purity hydrogen peroxide and high-purity sulfuric acid, which will contribute to increased fixed asset depreciation[5]. Financial Commitments - Financial expenses are expected to rise by approximately 400 thousand RMB due to commitments related to the acquisition of assets through stock issuance for a subsidiary[6]. Performance Forecast Disclaimer - The company emphasizes that the performance forecast data is preliminary and has not been audited, with detailed financial data to be disclosed in the 2024 annual report[7].